全球女性健康治療市場：規模、研究和預測，按類型（傳染病、妊娠、癌症），區域分析，2022-2029 年

2021 年全球女性保健藥物市場價值約為 1513.3 億美元，並將在 2022-2029 年預測期內以超過 10.0% 的增長率穩步增長。

旨在識別和增強女性健康的醫療程序、工具和服務被稱為女性健康療法。 由於女性慢性病發病率的增加以及對避孕藥具的需求以防止意外懷孕等因素，女性健康治療市場正在增長。 由於癌症和傳染病的早期發現、與懷孕有關的困難以及強大的新藥的出現，預計醫療成本上升也將進一步推動市場。

世界衛生組織報告稱，2020 年將有 230 萬女性被診斷出患有乳腺癌，高於 2012 年的 168 萬。 此外，古特馬赫研究所 2021 年 3 月的一篇研究文章估計，印度約有 240 萬青春期女性希望避孕並需要現代避孕措施。 因此，癌症患病率的上升和對預防意外懷孕的避孕藥具的需求正在推動市場增長。 此外，新藥治療意識的提高和新藥治療的引入以及女性傳染病的高流行率正在推動市場的有利增長。 然而，女性健康療法的高成本阻礙了整個 2022-2029 年預測期內的市場增長。

全球女性健康療法市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於品牌產品的主導地位、目標人群的增加以及對產品開發活動的投資增加，亞太地區在收入方面佔據了市場主導地位。 另一方面，由於老年人口和目標人口的增加、生物仿製藥開發研究合作的增加、大公司的地域擴張以及政府和非營利組織的市場准入等因素，北美將在預測期內增長最快. 預計將以高複合年增長率增長。

近期市場趨勢

• 2021 年 1 月，Sun Pharmaceutical Industries Ltd. 和 Ferring Pharmaceuticals Pvt. Ltd. 在印度推出了用於預防產後出血的產科藥物 CARITEC。
• 2018 年 5 月，輝瑞啟動了 Avelumab 的 3 期試驗，Avelumab 是一種可與化療聯合使用的卵巢癌藥物。 預計這將增加治療的□□實施並為社區和客戶提供一流的護理。

全球女性健康治療市場報告範圍

• 歷史數據：2019-2020-2021
• 估算基準年：2021 年
• 預測期：2022-2029
• 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
• 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
• 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

• 市場概況
• 2019-2029 年各細分市場的全球市場估計和預測
  • 2019-2029 年按地區劃分的女性健康治療市場
  • 女性健康治療市場，按類型，2019-2029
• 主要趨勢
• 調查方法
• 調查先決條件

第 2 章。全球女性健康治療市場的定義和範圍

• 調查目的
• 市場定義和範圍
  • 調查範圍
  • 工業發展
• 調查年份
• 貨幣兌換率

第 3 章女性健康療法的全球市場動態

• 女性健康治療市場影響分析（2019-2029 年）
  • 市場驅動因素
    • 女性慢性病發病率增加
    • 對預防意外懷孕的避孕藥具的需求
  • 市場挑戰
    • 昂貴的醫療費用
  • 市場機會
    • 提高對新藥療法的認識並加強介紹
    • 女性傳染病患病率高

第 4 章全球女性健康治療市場行業分析

• 波特 5 力模型
  • 供應商的議價能力
  • 買家的議價能力
  • 新進入者的威脅
  • 替代品的威脅
  • 競爭公司之間的敵對關係
• 波特 5 力模型的未來方法 (2019-2029)
• 害蟲分析
  • 政治
  • 經濟的
  • 社交
  • 技術
• 最佳投資機會
• 關鍵成功策略
• 業內人士的前景
• 分析師的建議和結論

第 5 章風險評估 COVID-19 影響

• 評估 COVID-19 對行業的總體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章女性健康治療的全球市場：按類型

• 市場概況
• 全球女性健康治療市場：按類型、按性能 - 潛力分析
• 2019-2029 年按類型分列的女性保健治療藥物全球市場估計和預測
• 女性健康治療市場，細分分析
  • 感染
  • 懷孕了
  • 腫瘤學

第 7 章。女性健康治療的全球市場：區域分析

• 女性健康治療市場，按地區劃分的市場概況
• 北美
  • 美國
    • 2019-2029 年按產品估算和預測
  • 加拿大
• 歐洲女性健康療法市場概況
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區女性健康療法市場概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 其他亞太地區
• 拉丁美洲女性健康療法市場概況
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 世界其他地區

第 8 章衝突信息

• 頂級市場策略
• 公司簡介
  • 拜耳公司
    • 關鍵信息
    • 概覽
    • 財務（僅當數據可用時）
    • 產品概覽
    • 近期趨勢
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Novartis AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd

第9章研究過程

• 研究過程
  • 數據挖掘
  • 分析
  • 市場評估
  • 驗證
  • 出版
• 調查的特點
• 調查先決條件

Global Women's Health Therapeutics Market is valued approximately USD 151.33 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.0% over the forecast period 2022-2029. Medical procedures, tools, and services aimed at identifying and enhancing women's health are referred to as therapeutics for women's health. The Women's Health Therapeutics market is expanding because of factors such as growing incidence of chronic health conditions among women, demand for contraceptives to prevent unintended pregnancies. In addition, rising healthcare spending for cancer and infectious disease early detection, pregnancy-related difficulties, and the introduction of new and potent medications are projected to further propel the market.

According to report from world health organization, in 2020, there were 2.3 million women diagnosed with breast cancer which increased from 1.68 million in year 2012. Furthermore, According to a research article by Guttmacher Institute in March 2021, it was estimated that approximately 2.4 million of adolescent women in India want to avoid pregnancy and in need of modern contraception. Thus, the rise in prevalence of cancer and demand for Contraceptives to Prevent Unintended Pregnancies is fostering the market growth. In addition, growing awareness and introduction of new drug therapies, High prevalence of infectious diseases among women is creating a lucrative growth to the market. However, the high cost of Women's Health Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women's Health Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific dominated the market in terms of revenue, owing to the dominance of branded products, rising target population, rising investment in product development activities. Whereas North America is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

• Bayer AG
• Merck & Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Novartis AG
• GlaxoSmithKline plc
• F. Hoffmann-La Roche Ltd

Recent Developments in the Market:

• In January 2021, to prevent postpartum bleeding, Sun Pharmaceutical Industries Ltd. and Ferring Pharmaceuticals Pvt. Ltd. launched the obstetric medication CARITEC in India.
• In May 2018, Pfizer initiated a Phase III trial for the ovarian cancer drug Avelumab, which can be used in conjunction with chemotherapy. This is anticipated to increase their treatment offerings and provide communities and customers with top-notch care.

Global Women's Health Therapeutics Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Type, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Infection
• Pregnancy
• Oncology

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Women's Health Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Women's Health Therapeutics Market, by Type, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Women's Health Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Women's Health Therapeutics Market Dynamics

• 3.1. Women's Health Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growing Incidence of Chronic Health Conditions Among Women
    • 3.1.1.2. Demand for Contraceptives to Prevent Unintended Pregnancies
  • 3.1.2. Market Challenges
    • 3.1.2.1. High cost of therapies
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Growing awareness and introduction of new drug therapies
    • 3.1.3.2. High prevalence of infectious diseases among women

Chapter 4. Global Women's Health Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Women's Health Therapeutics Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Women's Health Therapeutics Market by Type, Performance - Potential Analysis
• 6.3. Global Women's Health Therapeutics Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
• 6.4. Women's Health Therapeutics Market, Sub Segment Analysis
  • 6.4.1. Infection
  • 6.4.2. Pregnancy
  • 6.4.3. Oncology

Chapter 7. Global Women's Health Therapeutics Market, Regional Analysis

• 7.1. Women's Health Therapeutics Market, Regional Market Snapshot
• 7.2. North America Women's Health Therapeutics Market
  • 7.2.1. U.S. Women's Health Therapeutics Market
    • 7.2.1.1. Product breakdown estimates & forecasts, 2019-2029
  • 7.2.2. Canada Women's Health Therapeutics Market
• 7.3. Europe Women's Health Therapeutics Market Snapshot
  • 7.3.1. U.K. Women's Health Therapeutics Market
  • 7.3.2. Germany Women's Health Therapeutics Market
  • 7.3.3. France Women's Health Therapeutics Market
  • 7.3.4. Spain Women's Health Therapeutics Market
  • 7.3.5. Italy Women's Health Therapeutics Market
  • 7.3.6. Rest of Europe Women's Health Therapeutics Market
• 7.4. Asia-Pacific Women's Health Therapeutics Market Snapshot
  • 7.4.1. China Women's Health Therapeutics Market
  • 7.4.2. India Women's Health Therapeutics Market
  • 7.4.3. Japan Women's Health Therapeutics Market
  • 7.4.4. Australia Women's Health Therapeutics Market
  • 7.4.5. South Korea Women's Health Therapeutics Market
  • 7.4.6. Rest of Asia Pacific Women's Health Therapeutics Market
• 7.5. Latin America Women's Health Therapeutics Market Snapshot
  • 7.5.1. Brazil Women's Health Therapeutics Market
  • 7.5.2. Mexico Women's Health Therapeutics Market
  • 7.5.3. Rest of Latin America Women's Health Therapeutics Market
• 7.6. Rest of The World Women's Health Therapeutics Market

Chapter 8. Competitive Intelligence

• 8.1. Top Market Strategies
• 8.2. Company Profiles
  • 8.2.1. Bayer AG
    • 8.2.1.1. Key Information
    • 8.2.1.2. Overview
    • 8.2.1.3. Financial (Subject to Data Availability)
    • 8.2.1.4. Product Summary
    • 8.2.1.5. Recent Developments
  • 8.2.2. Merck & Co., Inc.
  • 8.2.3. Pfizer, Inc.
  • 8.2.4. Teva Pharmaceutical Industries Ltd.
  • 8.2.5. AstraZeneca
  • 8.2.6. Bristol-Myers Squibb Company
  • 8.2.7. Eli Lilly and Company
  • 8.2.8. Novartis AG
  • 8.2.9. GlaxoSmithKline plc
  • 8.2.10. F. Hoffmann-La Roche Ltd

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Women's Health Therapeutics Market, report scope
• TABLE 2. Global Women's Health Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Women's Health Therapeutics Market estimates & forecasts by Product 2019-2029 (USD Billion)
• TABLE 4. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 5. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Women's Health Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Women's Health Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. U.S. Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. U.S. Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. Canada Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. Canada Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. UK Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. UK Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Germany Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Germany Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. France Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. France Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Italy Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Italy Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Spain Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. Spain Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. RoE Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. RoE Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. China Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. China Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. India Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. India Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Japan Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Japan Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. South Korea Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 48. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 49. South Korea Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. Australia Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 51. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 52. Australia Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. RoAPAC Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. Brazil Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 57. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 58. Brazil Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Mexico Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 60. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 61. Mexico Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. RoLA Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 63. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 64. RoLA Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. Row Women's Health Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 66. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 67. Row Women's Health Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. List of secondary sources, used in the study of global Women's Health Therapeutics Market
• TABLE 69. List of primary sources, used in the study of global Women's Health Therapeutics Market
• TABLE 70. Years considered for the study
• TABLE 71. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Women's Health Therapeutics Market, research methodology
• FIG 2. Global Women's Health Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Women's Health Therapeutics Market, key trends 2021
• FIG 5. Global Women's Health Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Women's Health Therapeutics Market, porters 5 force model
• FIG 7. Global Women's Health Therapeutics Market, pest analysis
• FIG 8. Global Women's Health Therapeutics Market, value chain analysis
• FIG 9. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Women's Health Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Women's Health Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Women's Health Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Women's Health Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable